Drugs / BCD-148
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04027803 | Sep 2018 → Apr 2019 | — | Biocad | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCD-148 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04027803 ↗ |
| Route | Intravenous | “single intravenous infusion of BCD-148 (900 mg)” NCT04027803 ↗ |